Another study showing the oncogenic role of miR-182 has established that miR-182-5p is upregulated in serum and tissue samples of NSCLC patients, and its overexpression could considerably suppress AGER mRNA and protein expression. Here, AGER is linked to non-small cell lung carcinoma.